tradingkey.logo
tradingkey.logo
Search

Bristol Myers plans to launch schizophrenia drug in UK at list price equal to the US

ReutersSep 22, 2025 11:22 AM
facebooktwitterlinkedin

- Bristol Myers Squibb BMY.N said on Monday that it plans to launch its schizophrenia treatment Cobenfy in the UK in 2026 at a price that is equal to its US list price.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI